FRAZIER KENNETH C 4
4 · Eikon Therapeutics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
FRAZIER KENNETH C
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-03-02+25,873→ 25,873 totalExercise: $14.88Exp: 2036-03-01→ Common Stock (25,873 underlying)
Footnotes (1)
- [F1]1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.
Signature
/s/ Benjamin Thorner, Attorney-in-Fact|2026-03-04